Complementary low-level laser therapy for breast cancer-related lymphedema: a pilot, double-blind, randomized, placebo-controlled study
Kilmartin L, Denham T, Fu MR, Yu G, Kuo TT, Axelrod D, Guth AA
Lasers in medical science · 24 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2019-05-11 · Lasers Med Sci · vol. 35 · número 1 · págs. 95–105
- Editorial
- Springer Science+Business Media
- Citado
- 51 citas · más que el 89% de estudios similares · 2.5× el promedio de su campo
- Referencias
- 43 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY
- Áreas de investigación
- Laser Applications in Dentistry and Medicine · Lymphatic System and Diseases · Cancer survivorship and care
- Palabras clave
- low-level laser therapy, breast cancer-related lymphedema, complementary therapy, complete decongestive therapy, lymphedema symptoms, emotional distress, limb volume
- MeSH
- humans, breast neoplasms, lymphedema, placebos, treatment outcome, double-blind method, patient compliance, middle aged, female, low-level light therapy
7 autores
- Laurie Kilmartin🇺🇸NYU Langone Health; Rusk Rehabilitation; New York University
- Tara Denham🇺🇸NYU Langone Health; Rusk Rehabilitation; New York University
- Mei Rosemary Fu🇺🇸 · autor de correspondenciaNew York University
- Gary Yu🇺🇸New York University
- Ting-Ting Kuo🇺🇸Memorial Sloan Kettering Cancer Center
- Deborah Axelrod🇺🇸NYU Langone Health; New York University
- Amber Azniv Guth🇺🇸NYU Langone Health; New York University
Resumen
El texto original del estudio, en el idioma en que se publicó.
This pilot, double-blind, randomized, placebo-controlled study is aimed at evaluating the effectiveness of low-level laser therapy (LLLT) as a complementary treatment to complete decongestive therapy (CDT) treating lymphedema among breast cancer patients for 12 months post-intervention. Study population was breast cancer patients who were diagnosed and referred to lymphedema clinic for CDT. Participants (n = 22) were randomized and assigned into either an active laser intervention group or an inactive laser placebo-control group. Active LLLT was administered to participants twice a week at the beginning of each CDT session. Outcome measures included lymphedema symptoms, symptom distress, and limb volume by an infrared perometer. Participants in the active and placebo laser groups were comparable in demographic and clinical predictors of lymphedema. In comparison with the placebo group (83.3%), significantly fewer participants in the active laser group (55.6%) reported more than one lymphedema symptom (p = 0.012) at 12 months post-intervention. Significantly, more patients in the active laser group (44.4%) reported less than two impaired limb mobility symptoms in comparison with the placebo group (33.3%) at 12 months post-intervention (p = 0.017). The active laser group had statistically significant improvements in symptom distress of sadness (p = 0.005) from 73 to 11% and self-perception (p = 0.030) from 36 to 0% over time from baseline to 12-months post-intervention. There was no significant reduction in limb volume. Findings of the trial demonstrated significant benefits of complementary LLLT for relieving symptoms and improvement of emotional distress in breast cancer patients with lymphedema.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.